...

Biotech

Andrew Wu
From Portfolios

How Mesh Bio uses digital twin to predict disease 3 years early

Mesh Bio is transforming the healthcare landscape through its proprietary digital twin technology and predictive analytics platform, built at the intersection of computational biology and artificial intelligence.  By utilizing sophisticated mathematics to model internal biological mechanisms, Mesh Bio enables physicians to visualize a patient’s unique…
|
Press Release

PathGen raises funding from East Ventures and Royal Group Indonesia, making early disease detection and precision medicine more accessible

PathGen or PathGen Diagnostik Teknologi, an Indonesia-based healthcare biotechnology startup specializing in molecular testing solutions, announced today that it has raised funding from East Ventures, a pioneering and leading sector-agnostic venture capital firm in Indonesia and Southeast Asia, and Royal Group Indonesia, a dynamic and…
Rising biotech innovations to address Indonesia's healthcare problems
Insights

Rising biotech innovations to address Indonesia’s healthcare problems

With an over 270 million population, Indonesia remains an emerging medical market, supported by the surge of healthcare awareness demanded by the rising middle-income community. However, the country has faced chronic problems as the pandemic unveils shortcomings and an elevated sense of urgency to develop…